Literature DB >> 11242445

Biological activities of bovine glycomacropeptide.

E P Brody1.   

Abstract

Biological activity of bovine kappa-caseino glycomacropeptide (GMP) has received much attention in recent years. Research has focused on the ability of GMP to bind cholera and Escherichia coli enterotoxins, inhibit bacterial and viral adhesion, suppress gastric secretions, promote bifidobacterial growth and modulate immune system responses. Of these, protection against toxins, bacteria, and viruses and modulation of the immune system are the most promising applications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11242445     DOI: 10.1017/s0007114500002233

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  32 in total

1.  Glycomacropeptide administration attenuates airway inflammation and remodeling associated to allergic asthma in rat.

Authors:  Nuria Renata Roldán; Mariela Jiménez; Daniel Cervantes-García; Estefanía Marín; Eva Salinas
Journal:  Inflamm Res       Date:  2016-01-11       Impact factor: 4.575

Review 2.  Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.

Authors:  Sandra C van Calcar; Denise M Ney
Journal:  J Acad Nutr Diet       Date:  2012-08       Impact factor: 4.910

Review 3.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

4.  Top-down analysis of highly post-translationally modified peptides by Fourier transform ion cyclotron resonance mass spectrometry.

Authors:  Andres Guerrero; Larry Lerno; Daniela Barile; Carlito B Lebrilla
Journal:  J Am Soc Mass Spectrom       Date:  2014-11-18       Impact factor: 3.109

5.  Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.

Authors:  Patrick Solverson; Sangita G Murali; Adam S Brinkman; David W Nelson; Murray K Clayton; Chi-Liang Eric Yen; Denise M Ney
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-31       Impact factor: 4.310

6.  Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria.

Authors:  Erin L MacLeod; Murray K Clayton; Sandra C van Calcar; Denise M Ney
Journal:  Mol Genet Metab       Date:  2010-04-14       Impact factor: 4.797

Review 7.  Nutritional management of PKU with glycomacropeptide from cheese whey.

Authors:  D M Ney; S T Gleason; S C van Calcar; E L MacLeod; K L Nelson; M R Etzel; G M Rice; J A Wolff
Journal:  J Inherit Metab Dis       Date:  2008-10-29       Impact factor: 4.982

8.  Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice.

Authors:  Emily A Sawin; Travis J De Wolfe; Busra Aktas; Bridget M Stroup; Sangita G Murali; James L Steele; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

Review 9.  Beneficial health effects of milk and fermented dairy products--review.

Authors:  L Ebringer; M Ferencík; J Krajcovic
Journal:  Folia Microbiol (Praha)       Date:  2008-12-16       Impact factor: 2.099

10.  Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17.

Authors:  P Requena; A Daddaoua; E Martínez-Plata; M González; A Zarzuelo; M D Suárez; F Sánchez de Medina; O Martínez-Augustin
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.